Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "company"

5399 News Found

Kalahandi gets a major healthcare boost as Vedanta launches 24x7 telemed service
Healthcare | May 08, 2026

Kalahandi gets a major healthcare boost as Vedanta launches 24x7 telemed service

Initiative launched with Tata 1mg to benefit 70,000 people across 70 remote villages in Kalahandi region


Thyrocare Q4 PAT surges 128% to Rs. 48.7 crore
Healthcare | May 08, 2026

Thyrocare Q4 PAT surges 128% to Rs. 48.7 crore

Diagnostic major processes 59 million tests in Q4FY26 as revenue rises 20% and specialty testing portfolio expands


Roche moves to acquire PathAI for up to $1.05 billion in major AI pathology push
News | May 08, 2026

Roche moves to acquire PathAI for up to $1.05 billion in major AI pathology push

The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities


Uttar Pradesh poised to become India’s premier healthcare and medical device hub: Dr. G.N. Singh
Policy | May 08, 2026

Uttar Pradesh poised to become India’s premier healthcare and medical device hub: Dr. G.N. Singh

Former DCGI and now advisor to UP CM highlights medical device growth, healthcare expansion, and investment opportunities in the state


Dabur profit jumps 16% as FMCG growth gains pace
News | May 08, 2026

Dabur profit jumps 16% as FMCG growth gains pace

Hair care & quick commerce shine


Vijaya Diagnostic Q4FY26 revenue jumps 27%, EBITDA margin expands to 43.5%
Healthcare | May 08, 2026

Vijaya Diagnostic Q4FY26 revenue jumps 27%, EBITDA margin expands to 43.5%

With robust FY26 growth, plans AI-led diagnostics and genomic testing expansion


MilliporeSigma lands exclusive 5-year deal to test Genetix Biotherapeutics gene therapies
Biotech | May 08, 2026

MilliporeSigma lands exclusive 5-year deal to test Genetix Biotherapeutics gene therapies

The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy


Cirena licenses Agilent RNA purification tech to unlock high-purity long RNA for genome editing
Technology | May 08, 2026

Cirena licenses Agilent RNA purification tech to unlock high-purity long RNA for genome editing

The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides


CARBOGEN AMCIS Shanghai site clears unannounced NMPA GMP inspection
News | May 07, 2026

CARBOGEN AMCIS Shanghai site clears unannounced NMPA GMP inspection

Successful inspection outcome strengthens company’s regulatory compliance and manufacturing standards in China


Venus Remedies gets marketing authorization for Ceftriaxone in Argentina
Drug Approval | May 07, 2026

Venus Remedies gets marketing authorization for Ceftriaxone in Argentina

Approval strengthens the company’s growing international anti-infective portfolio